Does prostate cancer grow slowly?

Usually, yes. Prostate cancer typically grows very slowly. The National Cancer Institute goes one step further: finding and treating it before symptoms occur may not improve men's health or help them live longer.

That sentence overturns the usual rule about cancer, so it is worth unpacking rather than accepting.

Why slow growth changes the arithmetic

With most diseases, earlier is better. Prostate cancer breaks that pattern because many of these tumors grow so slowly that they would never have caused symptoms, illness, or death.

Finding such a tumor is called overdiagnosis. Treating it is called overtreatment. Neither term implies anyone made a mistake; there is often no reliable way to tell in advance which tumor is which.

The scale is large. The U.S. Preventive Services Task Force reports that 20% to 50% of prostate cancers found through screening may be overdiagnosed. Modeling of US cases diagnosed between 1988 and 2000 put the figure at 22% to 42%.

Treatment is not free of consequence, which is what makes overtreatment matter. Among men who have a radical prostatectomy, about 1 in 5 develop long-term urinary incontinence and 2 in 3 have long-term erectile dysfunction. Among men who have radiation therapy, more than half have long-term erectile dysfunction and up to 1 in 6 have long-term bothersome bowel symptoms.

The exception you cannot ignore

Usually slow is not always slow. Some prostate cancers are aggressive, spread, and kill. Prostate cancer is the most common cancer among men in the United States and the second leading cause of cancer death among them.

So the real question is never "is prostate cancer slow." It is "is mine." That is what grading, imaging, and sometimes repeat biopsies are for.

What a PSA number does and does not mean

PSA, or prostate-specific antigen, is a protein produced by both normal and cancerous cells of the prostate. A PSA level above 4.0 ng/mL is generally considered abnormal, though some doctors use a higher cutoff such as 5 ng/mL for older men and a lower one such as 2.5 ng/mL for younger men.

Plenty of harmless things push the number up. Benign prostatic hyperplasia, an enlarged prostate that comes with age, is a common cause, and so is prostatitis, inflammation of the gland. An infection or a recent prostate biopsy can keep PSA raised for a month or two. Vigorous exercise such as cycling, and ejaculation, can raise it briefly.

Screening reflects all of this uncertainty. For men aged 55 to 69 the Task Force calls the decision an individual one. For men 70 and older it recommends against PSA-based screening. Across roughly 13 years, screening may prevent about 1.3 prostate cancer deaths per 1,000 men screened. In one trial site, more than 45% of men who attended every screening round had at least one false-positive result over 10 years.

What to do with this

If your PSA comes back slightly high, ask for a repeat before agreeing to anything else. Ask whether an infection could explain it, and avoid cycling and ejaculation in the days before the retest.

If you are diagnosed, ask two questions before treatment is scheduled. How aggressive does this cancer look under the microscope, and what grade was assigned? And is active surveillance a reasonable option for me?

Active surveillance means monitoring the cancer with regular PSA tests, exams, imaging, and repeat biopsies, and treating only if it shows signs of growing. For slow tumors it avoids the side effects above without giving up the option to treat. Asking about it is not refusing care. It is asking which cancer you actually have.